Table 1.
Studies reported for use of GCSF for stem cell mobilization in pregnancy
| Characteristics/study | Leitner et al. [2] | Debus et al. [1] | Neidemener et al. [3] | Our case |
|---|---|---|---|---|
| Pregnancy duration (weeks) at time of exposure to GCSF | 8 | Peri-implantation | 29 | 21 |
| Trimester | First | First | Third | Second |
| Allogeneic/autologous | Allogeneic (NHL) | Allogeneic (AML) | Autologous (AML) | Allogeneic (SAA) |
| Weeks of gestation | 40 | 38 | 37 | 41 |
| Days of GCSF | 4 | 4 | 6 | 5 |
| CD34 dose (× 106/kg) | 2.05 | 6.4 | 19.8 | 2.14 |
| Birth weight (kg) | 3.4 | 2.95 | 1.7 | 3 |